FOR IN VITRO AND PRE-CLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE
Anti-Aging

NAD+ 500mg

500mg coenzyme research compound

From€79.00
In Stock · Ships within 48h
Reviews coming soonBe among the first to share your research experience.
Download Certificate of Analysis
  • EU Dispatch
  • CoA Included — Every Batch
  • Discreet Packaging
Purity≥98% HPLC
FormLyophilised Powder
Storage2–8°C
OriginEuropean Stock
DispatchWithin 48h
SKUUL-NAD-500MG
≥98% PureHPLC verified
HPLC TestedDual identity check
EU DispatchShips within 48h
CoA Incl.Every batch
Research Profile

Why NAD⁺ Fascinates Researchers

Nicotinamide adenine dinucleotide (NAD⁺) is a coenzyme found in every living cell, serving as the central redox carrier in cellular energy metabolism and as a substrate for a growing family of enzymes — sirtuins, PARPs, and CD38 — whose activity is inseparably linked to the molecule's availability. Its cellular concentration declines systematically with age, a finding that has made NAD⁺ biology one of the most actively studied fields in geroscience.

Central Role in Cellular Energetics

NAD⁺ functions as a hydride acceptor in glycolysis, the citric acid cycle, and beta-oxidation of fatty acids, cycling between its oxidised (NAD⁺) and reduced (NADH) forms to shuttle electrons to the mitochondrial electron transport chain. This continuous cycling is essential for ATP synthesis; disruptions to the NAD⁺/NADH ratio profoundly alter cellular metabolism. The total NAD⁺ pool — encompassing both NAD⁺ and NADH — represents one of the most highly conserved and abundant cellular metabolites across all domains of life.

Non-Redox Functions: Sirtuins, PARPs & CD38

Beyond its redox role, NAD⁺ is consumed — rather than recycled — as a co-substrate by three enzyme classes with profound implications for ageing biology. Sirtuins (SIRT1-7) are NAD⁺-dependent deacylases and ADP-ribosyltransferases that regulate chromatin structure, DNA repair, metabolic adaptation, and mitochondrial biogenesis. Poly(ADP-ribose) polymerases (PARPs) consume NAD⁺ during DNA damage responses. CD38 — a multifunctional ectoenzyme — is a major NAD⁺-consuming enzyme whose expression increases dramatically with age and inflammatory signalling, contributing significantly to the age-associated decline in cellular NAD⁺.

Age-Associated Decline & Preclinical Research

The observation that NAD⁺ levels in mammalian tissues decline 40–60% between young adulthood and old age — reported across rodent studies and corroborated by human blood metabolomics data — has been a driving force in NAD⁺ research. Rajman and colleagues synthesised this evidence in a landmark 2018 review in Cell Metabolism, identifying NAD⁺ decline as a potential mechanistic contributor to multiple hallmarks of ageing including impaired mitochondrial function, increased genomic instability, and reduced sirtuin activity.

A substantial body of preclinical work has examined whether restoring NAD⁺ levels — through direct supplementation or through precursors such as NMN and NR — can reverse functional markers of biological ageing in rodent models. Studies have reported improvements in skeletal muscle function, cognitive performance, cardiovascular parameters, and metabolic flexibility in aged mice following NAD⁺ or NAD⁺ precursor repletion. Mechanistic analyses have consistently implicated sirtuin reactivation and improved mitochondrial quality control as key downstream mediators of these effects.

This content is for informational purposes only and reflects the state of preclinical research. It does not constitute medical advice, endorsement of human use, or therapeutic claims of any kind.

Manufacturing Standards

Our Quality Commitment

HPLC Verified

Purity confirmed by High-Performance Liquid Chromatography at an accredited EU laboratory.

≥98% Purity

Every batch meets or exceeds 98% purity. CoA available for verification before dispatch.

Batch Traceability

Each vial is traceable to its synthesis batch, testing date, and analytical records.

Cold Chain Storage

European stock stored at optimal temperature from synthesis to dispatch.

48h EU Dispatch

Orders ship from EU stock within 48 hours with discrete, temperature-appropriate packaging.

CoA Included

Certificate of Analysis issued for every batch, available for download on request.

Download CoA for NAD+ 500mg
Peer-Reviewed Literature

Key Scientific Studies

Peer-reviewed research supporting NAD⁺ investigation.

[01]
Rajman L, Chwalek K, Sinclair DA. (2018) — Cell Metabolism

“Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence”

A comprehensive review synthesising preclinical evidence for NAD⁺ restoration strategies across ageing-relevant phenotypes. Authors systematically evaluate rodent studies demonstrating improvements in muscle function, neurocognition, cardiovascular parameters, and metabolic regulation following NAD⁺ or precursor repletion, and discuss mechanistic pathways including sirtuin activation and PARP modulation.

View on PubMed
[02]
Cantó C, Houtkooper RH, Pirinen E, et al. (2012) — Cell Metabolism

“The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity”

Landmark study demonstrating that NAD⁺ precursor supplementation in mice enhances oxidative metabolism, increases mitochondrial biogenesis via SIRT1/SIRT3 activation, and confers protection against high-fat diet-induced metabolic dysfunction. The study provided foundational mechanistic evidence linking NAD⁺ levels to sirtuin-mediated metabolic regulation.

View on PubMed
[03]
Yoshino J, Baur JA, Imai SI. (2018) — Cell Metabolism

“NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR”

Systematic evaluation of NAD⁺ biosynthetic intermediates and their biological roles, with particular focus on NMN and NR as research tools for NAD⁺ repletion. Authors compare pharmacokinetic properties, tissue distribution patterns, and reported biological effects across multiple model systems, providing a framework for experimental design in NAD⁺ biology research.

View on PubMed
[04]
Gomes AP, Price NL, Ling AJ, et al. (2013) — Cell

“Declining NAD⁺ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging”

Mechanistic investigation revealing that age-associated NAD⁺ decline disrupts communication between the nuclear and mitochondrial genomes, producing a pseudohypoxic state characterised by inappropriate HIF-1α stabilisation and impaired mitochondrial function. NAD⁺ repletion restored nuclear-mitochondrial communication and mitochondrial integrity in aged mouse muscle.

View on PubMed

All studies referenced are independent third-party research. UNIK LAB makes no claims regarding the therapeutic efficacy of any compound and does not represent or endorse the conclusions of cited studies. All referenced research was conducted under controlled laboratory or clinical conditions; results may not be predictive of effects in other experimental contexts.

Common Questions

Research FAQ

Answers to the most frequently asked questions about NAD⁺.

Same Category

Similar Compounds

Other Anti-Aging research compounds from our catalogue.

Your Longevity Research Guide Awaits

Subscribe to receive new compound profiles, CoA updates, and curated research digests — delivered directly to your inbox.